Myasthenia gravis (MG) is an autoimmune neuromuscular disorder that causes fluctuating muscle weakness. MG may be divided into an ocular form and a generalized form based on the involved muscles. Treatment differs between these different MG forms. The majority (80%) of patients with generalized MG are seropositive for antibodies against the acetylcholine receptor (AChR-Ab). Recently a new antibody was detected against muscle specific tyrosine kinase (MuSK) in about 40% of patients who are AChR-Ab seronegative. A few patients with MuSK-Abs have muscular atrophies, as well as electrophysiological myopathy. In this thesis we have characterized MuSK-Ab seropositive [MuSK(+)] patients using clinical parameters, including health-related quality o...
OBJECTIVES: To compare the clinical and electrophysiological features of myasthenia gravis (MG) pati...
In myasthenia gravis (MG) patients without detectable anti-acetylcholine receptor (anti-AChR) antibo...
Several reports from Western countries suggest differences in the clinical features of patients with...
Myasthenia gravis (MG) is an autoimmune neuromuscular disorder that causes fluctuating muscle weakne...
AIMS: We compared myopathological features in myasthenia gravis (MG) patients with antibodies again...
Patients with myasthenia gravis (MG) with antibodies to muscle-specific receptor tyrosine kinase (Mu...
Patients with myasthenia gravis (MG) with antibodies to muscle-specific receptor tyrosine kinase (Mu...
We assayed cryopreserved sera from 38 acetylcholine receptor (AChR) antibody-negative patients with ...
OBJECTIVE: Our aim was to study the pathophysiological process leading to facial muscle atrophy in 1...
Myasthenia gravis (MG) is an autoimmune disorder of the neuromuscular junction (NMJ). Most patients...
Abstract INTRODUCTION: Myasthenia gravis (MG) patients with autoantibodies to muscle-specific tyrosi...
Myasthenia Gravis (MG) is an autoimmune disorder affecting the neuromuscular junction. Muscle specif...
Myasthenia gravis (MG) is an antibody-mediated autoimmune disease of the neuromuscular junction. In ...
Myasthenia gravis (MG) with antibodies to muscle-specific kinase (MuSK) is an autoimmune disease of ...
A proportion of patients with myasthenia gravis (MG) without acetylcholine receptor (AChR) antibodie...
OBJECTIVES: To compare the clinical and electrophysiological features of myasthenia gravis (MG) pati...
In myasthenia gravis (MG) patients without detectable anti-acetylcholine receptor (anti-AChR) antibo...
Several reports from Western countries suggest differences in the clinical features of patients with...
Myasthenia gravis (MG) is an autoimmune neuromuscular disorder that causes fluctuating muscle weakne...
AIMS: We compared myopathological features in myasthenia gravis (MG) patients with antibodies again...
Patients with myasthenia gravis (MG) with antibodies to muscle-specific receptor tyrosine kinase (Mu...
Patients with myasthenia gravis (MG) with antibodies to muscle-specific receptor tyrosine kinase (Mu...
We assayed cryopreserved sera from 38 acetylcholine receptor (AChR) antibody-negative patients with ...
OBJECTIVE: Our aim was to study the pathophysiological process leading to facial muscle atrophy in 1...
Myasthenia gravis (MG) is an autoimmune disorder of the neuromuscular junction (NMJ). Most patients...
Abstract INTRODUCTION: Myasthenia gravis (MG) patients with autoantibodies to muscle-specific tyrosi...
Myasthenia Gravis (MG) is an autoimmune disorder affecting the neuromuscular junction. Muscle specif...
Myasthenia gravis (MG) is an antibody-mediated autoimmune disease of the neuromuscular junction. In ...
Myasthenia gravis (MG) with antibodies to muscle-specific kinase (MuSK) is an autoimmune disease of ...
A proportion of patients with myasthenia gravis (MG) without acetylcholine receptor (AChR) antibodie...
OBJECTIVES: To compare the clinical and electrophysiological features of myasthenia gravis (MG) pati...
In myasthenia gravis (MG) patients without detectable anti-acetylcholine receptor (anti-AChR) antibo...
Several reports from Western countries suggest differences in the clinical features of patients with...